DGB

DongKoo Bio & Pharma is a leading South Korean pharmaceutical company that has maintained the top position in the domestic dermatology prescription market for over a decade. The company specializes in a wide range of therapeutic areas, including dermatology, urology, and internal medicine, while aggressively expanding into the biotechnology and regenerative medicine sectors. Their proprietary SmartX platform, an automated stem cell extraction system, represents a significant advancement in cell therapy and aesthetics. With a robust pipeline of combination therapies and novel drug candidates, DongKoo Bio & Pharma is transitioning from a traditional manufacturer to an innovation-led global healthcare entity.